Home Tags Pharmaceuticals

Tag: Pharmaceuticals

Trade Associations—Under the Spotlight for Competition Enforcement

This article is part of a Chronicle. See more from this Chronicle Hong Kong Association of the Pharmaceutical Industry, Sep 30, 2015 The Competition Ordinance, Hong...

Reverse Payments Post Actavis: A Litigation Quagmire?

This article is part of a Chronicle. See more from this Chronicle Keith Hylton, Jul 15, 2015 For the last decade or so, the FTC has...

“Good Luck” Post-Actavis: Current State of Play on “Pay-for Delay” Settlements...

This article is part of a Chronicle. See more from this Chronicle Jonathan Lutinski, Ryan Maddock, Seth Silber, Dec 31, 2014 Chief Justice Roberts’ statement “good...

“Good Luck” Post-Actavis: Current State of Play on “Pay-for-Delay” Settlements

This article is part of a Chronicle. See more from this Chronicle Jonathan Lutinski, Ryan Maddock, Seth Silber, Nov 25, 2014 Chief Justice Roberts’ statement “good...

“Product Hopping” on Both Sides of the Pond: A Survey of...

This article is part of a Chronicle. See more from this Chronicle Michael Frese, Ingrid Vandenborre, Julia York, Nov 24, 2014 In recent years, courts in...

What’s Nexium After Actavis?

This article is part of a Chronicle. See more from this Chronicle Ankur Kapoor, Rosa Morales, Oct 29, 2014 As the first reverse-payment antitrust case to...

Refusal to Deal Under FDA Imposed Risk Evaluation and Mitigation Strategies...

This article is part of a Chronicle. See more from this Chronicle Robert Maness, Brian Segers, Apr 29, 2014 The Federal Trade Commission, as part of...

When Does Sharing Make Sense?: Antitrust & Risk Evaluation and Mitigation...

This article is part of a Chronicle. See more from this Chronicle Jan Rybnicek, Apr 29, 2014 There exists a new front in the battle to...

Defining “Payments”: The First Post-Actavis Battleground in Pharmaceutical Reverse Payments

This article is part of a Chronicle. See more from this Chronicle Lauren Battaglia, Apr 29, 2014 In June 2013, the Supreme Court ruled in FTC...

Courts’ Prescription for Reverse-Payment Settlements Still Unknown Almost a Year After...

This article is part of a Chronicle. See more from this Chronicle Ankur Kapoor, Rosa Morales, Apr 29, 2014 Nearly a year after the Supreme Court...
Enable Notifications    OK No thanks